Targeted Intervention on Sleep Disorders During Tobacco or Cannabis Cessation Therapy

Recruiting now · Not applicable

Conditions studied: Sleep Disorder

In brief

During a cessation therapy for tobacco or cannabis, sleep disorders are one of the main risk factors of relapse, and a symptom of substance withdrawing. In this study, we make the hypothesis that identifying and managing potential sleep disorders during cessation treatment may contribute to maintain tobacco / cannabis abstinence on the long-term. To evaluate the impact of such intervention, we will conduct a randomised pilot study among patients consulting at two addiction prevention and care centres, for smoking or cannabis use cessation treatment. Control group will benefit of usual care (a multidisciplinary care with individual and group therapies); intervention group will benefit in addition of a systematic screening of sleep disorders, and in case of a diagnosed alteration, they will be addressed to the Chronos centre, for specific care to help them manage and reduce the consequences of their sleep disorders. Participants will be followed over a 6-month period, with visits at 1 and 3 months, to monitor smoking or cannabis cessation, and other criteria associated with their substance use or sleep.

Key facts

Study ID

NCT07202351

Run by

Centre Hospitalier St Anne

People needed

80

Starts

2023-06-05

Expected to finish

2026-08-31

Last updated by the study team

2025-10-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients over 18 years old
• presenting at the participating addiction treatment centres for a smoking or cabannis use cessation therapy
• who agree to participate to the study
• affiliated to the French health insurance system

You may not qualify if…

• Patients hospitalised during the cessation therapy
• Patients undergoing sleep disorders treatment
• Patients participating to another study
• Patients with psychotic disorders (according the DSM-5 classification)
• Patients who do not want the additionnal intervention and care if randomised in the intervention group

Where it is running

• GHU Paris Psychiatrie et Neurosciences — Paris, Île-de-France Region, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.